IMAGE PHIAB.COM

PHI

MARKET CAP - 647M SEK
MARKET CAP - 647M SEK

ABOUT US

Phase Holographic Imaging AB (PHI) provides researchers in academia and the life science industry with products for live-cell kinetic studies. PHI’s time-lapse cytometer, the HoloMonitor® system, is based on our core technology holographic microscopy. Since introducing the first instrument in 2011, PHI now offers a range of products for label-free, long-term quantitative analysis of living cell dynamics, circumventing the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. The HoloMonitor system is a versatile tool providing detailed information about the life cycle and behavior of living, or dying, cells to scientists all over the world. Focus areas include basic cell research as well as the development of more efficient treatment strategies for cancer and other diseases. Committed to promoting the science and practice of time-lapse cytometry, PHI is continuously developing new products and applications in close collaboration with scientific expertise.

Q&A WITH PETER EGELBERG  

Right arrow

What have been the milestones so far in your company development?

Awaiting.

Right arrow

What are your most important markets, segments and customers?

Awaiting.

Right arrow

Where do you see the company five years from now?

Awaiting.

Right arrow

What are your priorities within 2020/21?

Awaiting.

Right arrow

Why should one consider adding your company into their portfolio?

Awaiting.

MEDIA